US Patent Issued to INTRADERM on Oct. 6 for "Embedded marker system and method for surface biopsy procedures and benign, malignant and suspicious lesions" (Maryland Inventor)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,625, issued on Oct. 6, was assigned to INTRADERM LLC (Columbia, Md.).

"Embedded marker system and method for surface biopsy procedures and benign, malignant and suspicious lesions" was invented by Melanie L. Adams (Columbia, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of marking the location of a skin biopsy by inserting a marker below the skin surface at or near the biopsy site."

The patent was filed on Feb. 11, 2016, under Application No. 15/041,881.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.ht...